Novavax COVID Vaccine Approval Delayed, Patients Fight for Access
The US Food and Drug Administration (FDA) has delayed the approval of Novavax’s COVID-19 booster vaccine, citing a need for additional clinical data. However, patients with long COVID and other groups who rely on the vaccine are fighting to keep it on the market. Novavax is the only COVID-19 booster that does not use messenger … Read more